Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle L Lamb

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 28, 2009
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitorsStephanos Ioannidis, Michelle L Lamb, Audrey M Davies, et al.
Journal of Medicinal Chemistry|January 23, 2004
Performance of 3D-database molecular docking studies into homology modelsConnie Oshiro, Erin K Bradley, John Eksterowicz, et al.
Journal of Molecular Graphics & Modelling|August 28, 2004
Design of a gene family screening library targeting G-protein coupled receptorsMichelle L Lamb, Erin K Bradley, Graham Beaton, et al.
Nature Chemical Biology|September 6, 2016
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chainGizem Akçay, Matthew A Belmonte, Brian Aquila, et al.
ACS Chemical Biology|July 31, 2013
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1Jiaquan Wu, Keith Mikule, Wenxian Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitorsTao Wang, Stephanos Ioannidis, Lynsie Almeida, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
Discovery of novel Jak2-Stat pathway inhibitors with extended residence time on targetHuiping Guan, Michelle L Lamb, Bo Peng, et al.
Journal of Medicinal Chemistry|July 31, 2019
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic MacrocyclesAmber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry|March 1, 2021
Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles"Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2017
Deconvoluting Kinase Inhibitor Induced CardiotoxicitySarah D Lamore, Ernst Ahlberg, Scott Boyer, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|October 28, 2009
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitorsStephanos Ioannidis, Michelle L Lamb, Audrey M Davies, et al.
Journal of Medicinal Chemistry|January 23, 2004
Performance of 3D-database molecular docking studies into homology modelsConnie Oshiro, Erin K Bradley, John Eksterowicz, et al.
Journal of Molecular Graphics & Modelling|August 28, 2004
Design of a gene family screening library targeting G-protein coupled receptorsMichelle L Lamb, Erin K Bradley, Graham Beaton, et al.
Nature Chemical Biology|September 6, 2016
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chainGizem Akçay, Matthew A Belmonte, Brian Aquila, et al.
ACS Chemical Biology|July 31, 2013
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1Jiaquan Wu, Keith Mikule, Wenxian Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitorsTao Wang, Stephanos Ioannidis, Lynsie Almeida, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
Discovery of novel Jak2-Stat pathway inhibitors with extended residence time on targetHuiping Guan, Michelle L Lamb, Bo Peng, et al.
Journal of Medicinal Chemistry|July 31, 2019
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic MacrocyclesAmber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry|March 1, 2021
Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles"Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2017
Deconvoluting Kinase Inhibitor Induced CardiotoxicitySarah D Lamore, Ernst Ahlberg, Scott Boyer, et al.
Pageof 5